Enliven Therapeutics Inc (ELVN)
Investing Cash Flow
-$441.57M
Quarterly · Period ending: · USD
ELVN Investing Cash Flow
Latest reported-$441.57Mperiod ending
Latest reported-$441.57Mperiod ending
ELVN Quarterly Cash from Investing ($0.00 → -$441.57M)
Quarterly investing cash flow
High-resolution chart · PNG
ELVN investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -441,566,000 | |
| 42,526,000 | |
| 12,379,000 | |
| -4,058,000 | |
| -183,589,000 | |
| 1,427,000 | |
| 727,000 | |
| 14,826,000 | |
| -33,665,000 | |
| -17,885,000 | |
| 38,686,000 | |
| -35,549,000 | |
| -151,518,000 | |
| -31,000 | |
| -101,000 | |
| -14,000 | |
| -303,000 | |
| -194,000 | |
| -14,491,000 | |
| -8,832,000 | |
| 3,388,000 | |
| 18,303,000 | |
| 21,212,000 | |
| -10,282,000 | |
| -32,408,000 | |
| 4,757,000 | |
| -2,112,000 | |
| -21,867,000 | |
| -81,000 | |
| 0 |